R. Eastell

Antiresorptive Versus Anabolic Therapy in Managing Osteoporosis in People with Type 1 and Type 2 Diabetes

T. Vilaca, R. Eastell, 2023, JBMR plus.

Diagnosis and management of bone fragility in diabetes: an emerging challenge

R. Eastell, W. Leslie, A. Schwartz, 2018, Osteoporosis International.

ICPE All Access conference abstracts

Debbie, W. Gellad, J. Kelman, 2020, Pharmacoepidemiology and Drug Safety.

Bone turnover in pregnancy, measured by urinary C-terminal telopeptide of type I collagen (CTX), is influenced by vitamin D supplementation and is associated with maternal bone health: Findings from the MAVIDOS trial.

A. Prentice, H. Inskip, K. Godfrey, 2021, The American journal of clinical nutrition.

CHAPTER 27 – Biochemical Markers of Bone Turnover

R. Eastell, 2007 .

DIAGNOSIS OF ENDOCRINE DISEASE Bone turnover markers: are they clinically useful?

K. Naylor, F. Gossiel, Jennifer Walsh, 2022 .

Efficacy of Osteoporosis Medications in Patients with Type 2 Diabetes

T. Vilaca, R. Eastell, 2023, Current osteoporosis reports.